References
- Fox PC, Brennan M, Pillemer S, Radfar L, Yamano S, Baum BJ. Sjögren's syndrome: a model for dental care in the 21st century. JADA. 1998;129:719-728.
- Carson, S. Sjögren's Syndrome. In: Harris E, Budd RC, Genovese, MC, Firestein GS, Sargent JS, eds. Kelley's Textbook of Rheumatology. 7th ed. St. Louis, MO: W.B. Saunders; 2005:chap 69.
- Data on file, Daiichi Sankyo, Inc.
- McArthur CP, Daniels PJ, Tishk M, Mayberry WE. Dental professionals' role in diagnosing Sjögren's syndrome. Gen Dent. 1997;45 (1):62-65.
- Parke AL, Buchanan WW. Sjögren's syndrome: history, clinical and pathological features. Inflammopharmacology. 1998;6 (3):271-287.
- Cotran RS, Kumar V, Robbins SL. Diseases of immunity. In: Schoen FJ, ed. Robbins Pathologic Basis of Disease. 5th ed. Philadelphia, Pa: WB Saunders Company; 1994:171-240.
- Stevens MB. Sjögren syndrome. In: Harvey AM, Johns RJ, McKusick VA, Owens AH, Ross RS, eds. The Principles and Practice of Medicine. 22nd ed. East Norwalk, Conn: Appleton & Lange; 1988:510-511.
- Anaya, JM, Talal, N. Sjögren's syndrome. In: Current Therapy in Allergy, Immunology, and Rheumatology. 5th ed. St. Louis, MO: Mosby-Year Book, Inc.; 1996: 204-212.
- Guggenheimer J, Moore PA. Xerostomia: Etiology, recognition and treatment. JADA. 2003;134:61-69.
- Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med. 2002;162:1293-1300.
- EVOXAC® (cevimeline HCl) Prescribing Information, Daiichi Sankyo, Inc., Edison, NJ, 11/2006.
- Petrone, D, Condemi JJ, Fife R, et al. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46:748-754.

